| Financial Year |
March 31 2023 |
| Monetary Funds |
1,809,502,902.74 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
61,071,188.96 |
| Accounts Receivable |
1,279,095,300.33 |
| Advances to Suppliers |
48,644,981.39 |
| Other Receivables |
289,070,602.53 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
35,091,719.92 |
| Dividend Receivable |
-- |
| Inventories |
5,477,836,835.65 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
51,586,519.44 |
| Total Current Assets |
9,016,808,331.04 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
2,137,063.59 |
| Investment Properties |
-- |
| Fixed Assetes |
902,869,944.24 |
| Under-construction Projects |
281,280,099.47 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
118,297,965.59 |
| R&D expenses |
97,046,575.73 |
| Goodwill |
123,804,611.13 |
| Long-Term Deferred and Prepaid Expenses |
1,338,237.65 |
| Deferred Income Tax Assets |
107,213,945.74 |
| Other Non-Current Assets |
15,825,050.24 |
| Sub-Total of Non-Current Assets |
1,726,125,097.40 |
| Total Assets |
10,742,933,428.44 |
| Short-Term Loans |
2,345,673,132.43 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,417,209.95 |
| Accounts Payable |
464,515,697.82 |
| Accounts Received In Advance |
1,373,907.56 |
| Employee Compensation Payable |
68,196,966.44 |
| Taxes Payable |
57,613,463.81 |
| Interest Payable |
6,033,441.86 |
| Dividend Payable |
-- |
| Other payables |
153,051,351.44 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
2,528,689.57 |
| Sub-Total of Current Liabilities |
3,104,938,938.68 |
| Long-term Loans |
500,000,000.00 |
| Bonds Payable |
495,245,902.74 |
| Long-Term Accounts Payable |
6,170,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
39,004,484.72 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,138,681,087.91 |
| Total Liabilities |
4,243,620,026.59 |
| Paid-In Capital(Or Share Stock) |
1,617,074,876.00 |
| Capital Surplus |
604,483,952.79 |
| Surplus Reserve |
476,826,504.71 |
| LESS:Treasury Stock |
32,824,352.06 |
| Undistributed Profits |
3,770,398,716.92 |
| Minority Stockholder's Interest |
-3,470,781.21 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,502,784,183.06 |
| Owner's Equity（Stockholder's Equity） |
6,499,313,401.85 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,742,933,428.44 |
